The rise and fall of apoptosis during multistage tumorigenesis: Down- modulation contributes to tumor progression from angiogenic progenitors

Genes and Development

Volumn 10, Issue 17, 1996, Pages 2105-2116

  Naik, Paul ^a   Karrim, Juliana ^a   Hanahan, Douglas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; bcl x(L); p53

Indexed keywords

PROTEIN P53;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; ONCOGENE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATOR GENE; TUMOR GROWTH;

ANIMALIA;

EID: 0029833679     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.17.2105     Document Type: Article

References (60)

1. Adams, J.M., A.W. Harris, C.A. Pinkert, L.M. Corcoran, W.S. Alexander, S. Cory, R.D. Palmiter, and R.L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhances induce lymphoid malignancy in transgenic mice. Nature 318: 533-538.
2. Alpert, S., D. Hanahan, and G. Teitelman. 1988. Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 53: 295-308.
3. Bakhshi, A., J.P. Jensen, P. Goldman, J.J. Wright, C.W. McBride, A.L. Epstein, and S.J. Korsmeyer. 1985. Cloning the chromosomal breakpoint of t(14;18) human lymphomas clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41: 899-906.
4. Barres, B.A., I.K. Hart, H.S. Coles, J.F. Burne, J.T. Voyvodic, W.D. Richardson, and M.C. Raff. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70: 31-46.
5. Bedi, A., P.J. Pasricha, A.J. Akhtar, J.P. Barber, G.G. Bedi, F.M. Giardiello, B.A. Zehnbauer, S.R. Hamilton, and R.J. Jones. 1993. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55: 1811-1816.
6. Berges, R.R., Y. Furuya, L. Remington, H.F. English, and T. Jacks. 1993. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc. Natl. Acad. Sci. 90: 8910-8914.
7. Boise, L.H., M. Gonzalez-Garcia, C. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez, and C.B. Thompson. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
8. Christofori, G., P. Naik, and D. Hanahan. 1994. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369: 414-418.
9. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
10. Cleary, M.L. and J. Sklar. 1985. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. 82: 7439-7443.
11. Cross, S.M., C.A. Sanchez, C.A. Morgan, M.K. Schimke, S. Ramel, R.L. Idzerda, W.H. Raskind, and B.J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356.
12. Dameron, K.M., O.V. Volpert, M.A. Tainsky, and N. Bouck. 1994. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584.
13. Debbas, M. and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Dev. 7: 546-554.
14. Donehower, L.A., M. Harvey, B.L. Slagle, M.J. McArthur, CA. Montgomery Jr., J.S. Butel, and A. Bradley. 1992. Mice deficient of p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
15. Efrat, S., S. Baekkeskov, D. Lane, and D. Hanahan. 1987. Coordinate expression of the endogenous p53 gene in beta cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes. EMBO J. 6: 2699-2704.
16. Evan, G.I, A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
17. Folkman, J., K. Watson, D. Ingber, and D. Hanahan. 1989. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61.
18. Hanahan, D. 1985. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/ simian virus 40 oncogenes. Nature 315: 115-122.
19. Harrington, E.A., M.R. Bennett, A. Fanidi, and G.I. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13: 3286-3295.
20. Hermeking, H. and D. Eick. 1994. Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091-2093.
21. Hockenberry, D., G. Nunez, C. Milliman, R.D. Schreiber, and S.J. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336.
22. Holmgren, L., M.S. O'Reilly, and J. Folkman. 1995. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1: 149-153.
23. Howes, K.A., N. Ransom, D.S. Papermaster, J.G.H. Lasudry, D.M. Albert, and J.J. Windle. 1994. Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes & Dev. 8: 1300-1310.
24. Jacks, T., A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295-300.
25. Kerr, J.F.R., J. Searle, B.V. Harmon, and C.J. Bishop. 1987. Apoptosis. In Perspectives on mammalian cell death (ed. C.S. Potten), pp. 93-128. Oxford University Press, Oxford, UK.
26. Korsmeyer, S.J. 1992. Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80: 879-886.
27. Lacy, P.E. and M. Kostianovsky. 1967. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39.
28. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993a. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967.
29. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993b. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
30. Ludlow, J.W. 1993. Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J. 7: 866-871.
31. McDonnell, T.J. and S.J. Korsmeyer. 1991. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349: 254-256.
32. McDonnell, T.J., P. Troncoso, S.M. Brisbay, C. Logothetis, L.W.K. Chung, J. Hsieh, S. Tu, and M.L. Campbell. 1992. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52: 6940-6944.
33. McDonnell, T.J., M.C. Marin, B. Hsu, S.M. Brisbay, K. McConnell, S.M. Tu, M.L. Campbell, and J. Rodriguez-Villanueva. 1993. The bcl-2 oncogene: Apoptosis and neoplasia. Radiat. Res. 136: 307-312.
34. Morgenbesser, S.D., B.O. Williams, T. Jacks, and R.A. DePinho. 1994. p53-Dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72-74.
35. Motoyama, N., F. Wang, K.A. Roth, H. Sawa, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, and D.Y. Loh. 1995. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267: 1506-1510.
36. Naik, P., G. Christofori, and D. Hanahan. 1994. Insulin-like growth factor II is focally up-regulated and functionally involved as a second signal for oncogene-induced tumorigenesis. Cold Spring Harbor Symp. Quant. Biol. 59: 459-470.
37. Oltvai, Z.N., C.L. Milliman, and S. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74: 609-619.
38. Oppenheim, R.W. 1991. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14: 453-501.
39. Osborne, C.K., E.B. Coronado, L.J. Kitten, C.I. Arteaga, S.A. Fuqua, and K. Ramaharma. 1989. Insulin-like growth factor-II: A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol. Endocrinol. 3: 1701-1709.
40. Pan, H. and A.E. Griep. 1994. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function development. Genes & Dev. 8: 1285-1299.
41. Parangi, S., W. Dietrich, G. Christofori, E.S. Lander, and D. Hanahan. 1995. Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma. Cancer Res. 55: 6071-6076.
42. Parangi, S., M. O'Reilly, G. Christofori, L. Holmgren, J. Grosfeld, J. Folkman, and D. Hanahan. 1996. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. 93: 2002-2007.
43. Raff, M. 1992. Social controls on cell survival and cell death. Nature 356: 397-400.
44. Schott, A.F., I.J. Apel, G. Nunez, and M.F. Clarke. 1995. Bcl-XL protects cancer cells from p53-mediated apoptosis. Oncogene 11: 1389-1394.
45. Strasser, A., A.W. Harris, M.L. Bath, and S. Cory. 1990. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331-333.
46. Strasser, A., A.W. Harris, T. Jacks, and S. Cory. 1994. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by bcl-2. Cell 79: 329-339.
47. Surh, C.D. and J. Sprent. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372: 100-103.
48. Symonds, H., L. Krall, L. Remington, M. Aenz-Robles, S. Lowe, T. Jacks, and T. Van Dyke. 1994. p53-Dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78: 703-711.
49. Takayama, S., T. Sato, S. Krajewski, K. Kochel, S. Irie, J.A. Millan, and J.C. Reed. 1995. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity. Cell 80: 279-284.
50. Teitelman, G., S. Alpert, and D. Hanahan. 1988. Proliferation, senescence, and neoplastic progression of beta cells in hyperplasic pancreatic islets. Cell 52: 97-105.
51. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
52. Tsujimoto, Y., J. Gorham, J. Cossman, E. Jaffe, and C.M. Croce. 1985. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229: 1390-1393.
53. Vaux, D.L., S. Cory, and T.M. Adams. 1988. Bcl-2 promotes the survival of hematopoietic cells and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
54. waf1/cip1. Genes & Dev. 8: 2817-2830.
55. Wahl, A.F., K.L. Donaldson, C. Fairchild, R.Y.F. Lee, S.A. Foster, G.W. Demers, and D.A. Galloway. 1996. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nature Med. 2: 72-79.
56. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes & Dev. 10: 1-15.
57. White, E., L. Rao, S.K. Chiou, C.C. Tseng, P. Sabbatini, M. Gonzalez, and P. Verwaerde. 1994. Regulation of apoptosis by the transforming gene products of adenovirus. In Apoptosis (ed. E. Mihich and R.T. Schimke), pp. 47. Plenum Press, New York, NY.
58. Wyllie, A.H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556.
59. Yee, D., N. Rosen, R.E. Favoni, and K.J. Cullen. 1991. The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. Cancer Treat. Res. 53: 93-106.
60. Ziegler, A., A.S. Jonason, D.J. Leffell, J.A. Simon, H.W. Sharma, J. Kimmelman, L. Remington, T. Jacks, and D.E. Brash. 1994. Sunburn and p53 in the onset of skin cancer. Nature 372: 773-776.